MSN Laboratories Private Limited — Darunavir Exporter Profile
Indian Pharmaceutical Exporter · #5 for Darunavir · $3.2M export value · DGFT Verified
MSN Laboratories Private Limited is the #5 Indian exporter of Darunavir with $3.2M in export value and 68 verified shipments. MSN Laboratories Private Limited holds a 5.2% market share in Darunavir exports across 9 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Darunavir Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Darunavir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $728.0K | 23 | 35.8% |
| UNITED STATES | $386.7K | 10 | 19.0% |
| ITALY | $350.9K | 10 | 17.3% |
| AUSTRALIA | $227.6K | 5 | 11.2% |
| ALGERIA | $172.2K | 6 | 8.5% |
| CANADA | $119.6K | 3 | 5.9% |
| MALTA | $14.8K | 8 | 0.7% |
| MOLDOVAREPUBLIC OF | $12.8K | 1 | 0.6% |
| MOLDOVA,REPUBLIC OF | $12.6K | 1 | 0.6% |
| MOLDOVA | $8.3K | 1 | 0.4% |
MSN Laboratories Private Limited exports Darunavir to 10 countries. The largest destination is UNITED KINGDOM accounting for 35.8% of MSN Laboratories Private Limited's Darunavir shipments, followed by UNITED STATES (19.0%) and ITALY (17.3%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Darunavir from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | UNITED KINGDOM | $588.7K | 14 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $296.4K | 7 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $200.0K | 4 |
| HEALTHCARE LOGISTICS | AUSTRALIA | $143.7K | 3 |
| MARCAN PHARMACEUTICALS INC., | CANADA | $119.6K | 3 |
| TILLOMED ITALY SRL | ITALY | $107.6K | 3 |
| STM GROUP GREZZAGO | ITALY | $104.5K | 4 |
| APOTEX PTY LTD | AUSTRALIA | $83.9K | 2 |
| MSN LABORATORIES EUROPE LIMITED., | UNITED KINGDOM | $73.1K | 2 |
| PHARMACIE CENTRALE DES HOPITAUX PCH | ALGERIA | $68.4K | 2 |
MSN Laboratories Private Limited supplies Darunavir to 23 buyers globally. The largest buyer is TO THE ORDER OF (UNITED KINGDOM), followed by TILLOMED LABORATORIES LIMITED (UNITED KINGDOM) and NOVADOZ PHARMACEUTICALS LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Darunavir Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $33.1M worth of Darunavir through 711 shipments from 28 suppliers to 114 countries, serving 258 buyers globally. MSN Laboratories Private Limited contributes $3.2M to this total, accounting for 5.2% of India's Darunavir exports. MSN Laboratories Private Limited ships Darunavir to 10 countries through 23 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Darunavir Exports?
MSN Laboratories Private Limited's average Darunavir shipment value is $46.4K per consignment, based on 68 shipments totaling $3.2M. The largest destination is UNITED KINGDOM (35.8% of MSN Laboratories Private Limited's Darunavir exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Darunavir Exporters?
MSN Laboratories Private Limited ranks #5 among 28 Indian Darunavir exporters with a 5.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($13.4M), HETERO LABS LIMITED ($11.3M), MSN LABORATORIES PRIVATE LIMITED ($3.2M). MSN Laboratories Private Limited processed 68 shipments to 9 destination countries.
What Darunavir Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MSN PHARMACEUTICAL PRODUCT NAME DARUNAVIR TILLOMED 800MG FCT 30S UK | $165.2K | 4 |
| DARUNAVIR TABS 800MG 30'S TILLOMED IT | $107.6K | 3 |
| DARUNAVIR TILLOMED 800MG FCT 30S UK | $100.0K | 2 |
| DARUNAVIR TILLOMED 800MG FCT 30S UK (30SPACK) (4920 PACKS)NOS | $96.4K | 3 |
| DARUNAVIR JUNO 800MG (30'S) JUNO AU | $83.9K | 2 |
| Darunavir tabs 800mg 30's Uk | $73.1K | 2 |
| MSN PHARMA DARUNAVIR TAB 800MG 30`S (MAR | $69.6K | 2 |
| DARUNAVIR TABS 800MG 30 S TILLOMED IT(MSN PHARMACEUTICAL PRODUCT NAME)NOS | $53.8K | 2 |
| DARUNAVIR TABS 600MG 60'S TILLOMED ITNOS | $50.7K | 2 |
| MSN PHARMA DARUNAVIR TABS 600MG 60 S TIL | $50.0K | 1 |
MSN Laboratories Private Limited exports 54 distinct Darunavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MSN PHARMACEUTICAL PRODUCT NAME DARUNAVIR TILLOMED 800MG FCT with 4 shipments worth $165.2K.
Regulatory Requirements: Exporting Darunavir to Key Markets
What MSN Laboratories Private Limited must comply with to export Darunavir to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Darunavir Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MYLAN LABORATORIES LIMITED | $13.4M | 269 | 56 | $50.0K |
| 1 | HETERO LABS LIMITED | $11.3M | 227 | 72 | $50.0K |
| 5 | MSN LABORATORIES PRIVATE LIMITED ★ | $3.2M | 68 | 9 | $46.4K |
| 4 | ANNORA PHARMA PRIVATE LIMITED | $2.8M | 55 | 5 | $50.0K |
| 6 | CIPLA LIMITED | $1.6M | 31 | 9 | $50.0K |
MSN Laboratories Private Limited ranks #5 among 28 Indian Darunavir exporters. Average shipment value of $46.4K compared to the market average of $1.2M. The closest competitors by value are MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Darunavir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 165 | 23.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 121 | 17.0% |
| HYDERABAD AIR | 85 | 12.0% |
| HYDERABAD ACC (INHYD4) | 59 | 8.3% |
| NHAVA SHEVA SEA (INNSA1) | 40 | 5.6% |
| HYDERABAD ICD (INSNF6) | 33 | 4.6% |
| HYDERABAD ICD | 30 | 4.2% |
| Bombay Air | 22 | 3.1% |
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Darunavir Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Darunavir, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Darunavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Darunavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 68 individual customs records matching MSN Laboratories Private Limited exporting Darunavir, covering 54 formulations to 10 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 258+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Darunavir Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Darunavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Darunavir Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Darunavir. For current shipment-level data, contact TransData Nexus.